Understanding how photoreceptors influence blood vessel growth in the retina

Photoreceptor Determination of Retinal Blood Vessel Growth in Retinopathy

NIH-funded research Boston Children's Hospital · NIH-10674833

This study is looking at how certain cells in the eye help control the growth of blood vessels in babies with retinopathy of prematurity (ROP), a condition that can cause blindness, to find better ways to prevent it and help those at risk.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston Children's Hospital NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-10674833 on NIH RePORTER

What this research studies

This research investigates the role of photoreceptors in the growth of blood vessels in the retina, particularly in the context of retinopathy of prematurity (ROP), a condition that can lead to blindness in infants. The study aims to uncover the molecular mechanisms behind ROP by examining how photoreceptors signal for blood vessel growth through inflammatory proteins. By using a mouse model, researchers will explore the function of a specific transcription factor, c-Fos, which regulates these inflammatory signals. The ultimate goal is to develop earlier preventative therapies for ROP, improving outcomes for at-risk infants.

Who could benefit from this research

Good fit: Ideal candidates for this research are premature infants who are at high risk for developing retinopathy of prematurity.

Not a fit: Patients who are not premature or do not have a diagnosis of retinopathy of prematurity may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new preventative treatments for retinopathy of prematurity, potentially reducing the incidence of blindness in affected infants.

How similar studies have performed: Other research has shown promise in understanding the role of inflammatory mediators in retinopathy, but the specific approach of targeting photoreceptor signaling in ROP is relatively novel.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.